Pleural well-differentiated papillary mesothelioma : A case report

Journal of Thoracic Oncology

Volumn 4, Issue 7, 2009, Pages 920-922

  Kao, Steven ^a   Mahon, Kate ^a   Lin, Betty ^b   Rutland, Jonathan ^c   Pawsey, Charles ^d   Mccaughan, Brian ^e   Beale, Philip ^a,d  

^a SYDNEY CANCER CENTRE   (Australia)

^b Departments of Anatomical Pathology

^c Respiratory Medicine

^d ANZAC Research Institute   (Australia)

^e ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Mesothelioma; Pleura; Well differentiated papillary mesothelioma

Indexed keywords

CA 125 ANTIGEN; CALRETININ; CYTOKERATIN; EPITHELIAL MEMBRANE ANTIGEN; IMATINIB; TAMOXIFEN; TUMOR MARKER;

ADULT; ANEMIA; ARTICLE; CANCER DIAGNOSIS; CANCER GROWTH; CASE REPORT; CAUSE OF DEATH; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; CYTOLOGY; DIAGNOSTIC IMAGING; DYSPNEA; ELECTRON MICROSCOPY; FATALITY; FEMALE; HEART TAMPONADE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PAIN; PERICARDIAL EFFUSION; PERICARDIOCENTESIS; PERICARDIOTOMY; PLEURA EFFUSION; PLEURA MESOTHELIOMA; PLEURA TUMOR; PLEURAL WELL DIFFERENTIATED PAPILLARY MESOTHELIOMA; PLEURODESIS; PRIORITY JOURNAL; RECURRENT DISEASE; RESPIRATORY FAILURE; SURVIVAL TIME; THORACOTOMY; TREATMENT DURATION; TUMOR CELL;

EID: 68549136814     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3181a97dc3     Document Type: Article

References (10)

1. Millward M, Parnis F, Byrne M, et al. Phase II trial of imatinib mesylate in patients with advanced pleural mesothelioma. Proc Am Soc Clin Oncol 2003;22:(abstract 912).
2. Butnor KJ, Sporn TA, Hammar SP, Roggli VL. Well-differentiated papillary mesothelioma. Am J Surg Pathol 2001;25:1304-1309.
3. Galateau-Salle F, Vignaud JM, Burke L, et al. Well-differentiated papillary mesothelioma of the pleura: a series of 24 cases. Am J Surg Pathol 2004;28:534-540. (Pubitemid 38436526)
4. Hollinger P, Gaeng D. Simultaneous bilateral spontaneous pneumothorax in a patient with peritoneal and pleural papillary mesothelioma. Respiration 1997;64:233-235. (Pubitemid 27179873)
5. Shukunami K, Hirabuki S, Kaneshima M, Kamitani N, Kotsuji F. Well-differentiated papillary mesothelioma involving the peritoneal and pleural cavities: successful treatment by local and systemic administration of carboplatin. Tumori 2000;86:419-421. (Pubitemid 30945177)
6. Ikeda K, Suzuki T, Tate G, Mitsuya T. Cytomorphologic features of well-differentiated papillary mesothelioma in peritoneal effusion: a case report. Diagn Cytopathol 2008;36:512-515. (Pubitemid 351897381)
7. Daya D, McCaughey WT. Well differentiated papillary mesothelioma of the peritoneum: a clinicopathologic study of 22 cases. Cancer 1990;5: 292-296. (Pubitemid 20035355)
8. Baratti D, Kusamura S, Nonaka D, Oliva GD, Laterza B, Deraco M. Multicystic and well-differentiated papillary peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC). Ann Surg Oncol 2007;14:2790-2797. (Pubitemid 47460640)
9. Kushitani K, Takeshima Y, Amatya VJ, Furonaka O, Sakatani A, Inai K. Immunohistochemical marker panels for distinguishing between epithelioid mesothelioma and lung adenocarcinoma. Pathol Int 2007;57:190-199. (Pubitemid 46279947)
10. Baratti D, Kusamura S, Martinetti A, et al. Circulating CA125 in patients with peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion. Ann Surg Oncol 2007;14:500-508. (Pubitemid 46175294)